IP Library Granted Patent US 8,026,383
Granted Patent B2
US 8,026,383 · App. 12/939,401 · Granted Sep 27, 2011

Process for the preparation of intermediates useful in the synthesis of statin derivatives

Assignee: BASF SE
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,026,383
App. No.
12/939,401
Granted
Sep 27, 2011
Kind
B2
Abstract

The invention relates to novel synthesis methods for the preparation of statin derivatives, which methods proceed by way of a key intermediate of formula I wherein X is halogen, acyloxy, activated hydrocarbyloxy, activated hydrocarbylthio or —N(CH 3 )OCH 3 , R a is a hydroxy-protecting group and R b is a carboxy-protecting group, and, as well as to the compound of formula I, to further new intermediates and methods for their preparation by Friedel-Crafts acylation.

Claims (23)

1. A process for the preparation of an intermediate compound of formula VI suitable for the preparation of statin derivatives, which process comprises reaction of an intermediate of formula I

wherein X is halogen, acyloxy, activated hydrocarbyloxy, activated hydrocarbylthio or —N(CH 3 )—OCH 3 , R a is a hydroxy-protecting group and R b is a carboxy-protecting group, with chain lengthening, including the following reaction steps, as described below, wherein the intermediate of formula I reacts with an ethylene of formula II

wherein Y a is halogen or hydrogen; there being obtained a keto compound of formula III

wherein Y a is halogen or hydrogen, X a is halogen or acyloxy, R a is hydrogen, obtainable after removal of a hydroxy-protecting group R a , or a hydroxy-protecting group and R b is a carboxy-protecting group; the compound of formula III is reacted further in accordance with the following method (3), wherein

a compound of formula III wherein X a is halogen or acyloxy, Y a is hydrogen, R a is hydrogen and R b is a hydroxy-protecting group is reacted diastereoselectively by means of a suitable reagent to form a syn-diol compound of formula Va

wherein X a is halogen or acyloxy, and R a ′ and R c ′ are as defined for compounds of formula V and R b is as defined for compounds of formula III; and the compound of formula Va is then reacted with a salt of hydrazoic acid to form a compound of formula V

wherein R a ′ and R c ′ are each hydrogen or, after subsequent introduction of protecting groups, R a ′ and R c ′ are each independently of the other hydrogen or a protecting group, with the proviso that at least one of the two radicals is a protecting group, or R a ′ and R c ′ together are a bridging hydroxy-protecting group, and R b is as defined above for compounds of formula III

and the compound of formula V so obtainable is then reduced to the corresponding amino compound of formula VI

wherein R a ′ and R c ′ are each independently of the other hydrogen or a hydroxy-protecting group or together are a bridging hydroxy-protecting group, and R b is a carboxy-protecting group;

wherein in the processes mentioned above, at any stage, even where not explicitly mentioned, if necessary one or more or all of the protecting groups present in the compounds of formulae I to VI in question are removed or one or more or all of the functional groups that are not to participate in a reaction, or that would interfere with the reaction, are converted into protected groups by the introduction of suitable protecting groups, and it being possible for the compounds of formulae Ito VI, where salt-forming groups are present and the reaction in question is not impaired, also to be in salt form.

2. A process according to claim 1 , wherein a compound of formula III, wherein X a is halogen and Y a is hydrogen, R a is hydrogen and R b is a carboxy-protecting group; is reacted diastereoselectively with hydrogen in the presence of an alkali metal salt or an alkaline-earth metal salt and a heterogeneous platinum catalyst to form a syn-diol compound of formula Va

wherein X a is halogen and R a ′, R c ′ and R b are as defined for compounds of formula V.

3. A process according to claim 1 wherein a compound of formula III is reacted diastereoselectively with a mixture of triethylborane or diethylborane methoxide with sodium borhydride to form a syn-diol compound of formula V.

4. A process according to claim 1 for the preparation of statin precursors of formula VI, which comprises as reaction steps the reaction of a key intermediate of formula I wherein X is halogen, acyloxy, activated hydrocarbyloxy, activated hydrocarbylthio or —N(CH 3 )OCH 3 , R a is a hydroxy-protecting group and R b is a carboxy-protecting group with an ethylene of formula II

wherein Y a is halogen or hydrogen; there being obtained a keto compound of formula III

wherein Y a is hydrogen, X a is halogen or acyloxy, R a is hydrogen, obtainable after removal of a hydroxy-protecting group R a , or a hydroxy-protecting group and R b is a carboxy-protecting group;

the conversion of the compound of formula III by means of a suitable reagent diastereoselectively to form a syn-diol compound of formula Va

wherein X a is halogen and R a ′ and R c ′ are as defined for compounds of formula III and R b is as defined for compounds of formula III; then the reaction of the compound of formula Va with a salt of hydrazoic acid to form a compound of formula V

wherein R a ′ and R c ′ are each hydrogen, or, after subsequent introduction of protecting groups, R a ′ and R c ′ are each independently of the other hydrogen or a protecting group, with the proviso that at least one of the two radicals is a protecting group, or R a ′ and IR c ′ together are a bridging hydroxy-protecting group; and R b is as defined above for compounds of formula III; and then reduction thereof to form an amino compound of formula VI;

and at any stage, even where not explicitly mentioned, if necessary one or more or all of the protecting groups present in the compounds of formulae I, Ill, Va, V and VI in question are removed or one or more or all of the functional groups that are not to participate in a reaction, or that would interfere with the reaction, are converted into protected groups by the introduction of suitable protecting groups, and it being possible for the compounds of formulae I, Ill and/or VII, where salt-forming groups are present and the reaction in question is not impaired, also to be in salt form.

5. A compound of formula Va

wherein X a is halogen or acyloxy, R a ′ is hydrogen and R c ′ is hydrogen, or R a ′ and R c ′ are each independently of the other hydrogen or a protecting group, with the proviso that at least one of the two radicals is a protecting group, or R a ′ and R c ′ together are a bridging hydroxy-protecting group; and R b is a carboxy-protecting group,

which compound is 7-chloro-3,5-dihydroxy-heptanoic acid ethyl ester or (3R,5R)-7-chloro-3,5-(2′,2′-isopropylidenedioxy)-heptanoic acid ethyl ester.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2011
From: OHRLEIN, REINHOLD; BAISCH, GABRIELE; END, NICOLE; BURKHARDT, STEPHAN; STUDER, MARTIN
To: CIBA SPECIALTY CHEMICALS CORPORATION
Reel/Frame 026741/0464 →
CHANGE OF NAME Recorded Aug 12, 2011
From: CIBA SPECIALTY CHEMICALS CORPORATION
To: CIBA CORPORATION
Reel/Frame 026741/0491 →
ASSET TRANSFER AGREEMENT Recorded Aug 12, 2011
From: CIBA CORPORATION
To: BASF SE
Reel/Frame 026741/0600 →
Priority Claims (1)
EP 01810670 · Jul 6, 2001 · regional
Continuity (3)
Division 12220390 · Jul 24, 2008
Division 10482463
Related Publication 20110046411A1 · Feb 24, 2011